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Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate
Use Criteria for Coronary Revascularization Focused Update: A Report of the American College of Cardiology
Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society
of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of
Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography (J Am Coll Cardiol 2011;59:857–881;
doi:10.1016/j.jacc.2011.12.001).
The following changes are needed to Table 4 (p. 869) to correct a transposition error:
• The ratings for indication #68 should be changed to A (7) for PCI and U (6) for CABG.
• The ratings for indication #69 should be changed to U (6) for PCI and A (8) for CABG.
A corrected table is reprinted below.
doi:10.1016/j.jacc.2012.02.014
Table 4. Method of Revascularization: Multivessel CAD, CCS Angina Greater Than or Equal to Class III, and/or Evidence of
Intermediate- to High-Risk Findings on Noninvasive Testing*
Indication
Appropriate
Use Score (1–9)
PCI CABG
62. ● Two-vessel CAD with proximal LAD stenosis A (7) A (8)
63. ● Three-vessel CAD with low CAD burden (i.e., 3 focal stenoses, low SYNTAX score) A (7) A (9)
64. ● Three-vessel CAD with intermediate to high CAD burden (i.e., multiple diffuse lesions, presence of
CTO, or high SYNTAX score)
U (4) A (9)
65. ● Isolated left main stenosis U (6) A (9)
66. ● Left main stenosis and additional CAD with low CAD burden (i.e., 1- to 2-vessel additional
involvement, low SYNTAX score)
U (5) A (9)
67. ● Left main stenosis and additional CAD with intermediate to high CAD burden (i.e., 3-vessel
involvement, presence of CTO, or high SYNTAX score)
I (3) A (9)
68. ● Prior bypass surgery with native 3-vessel disease and failure of multiple bypass grafts
● LIMA remains patent to a native coronary artery
● Depressed LVEF
A (7) U (6)
69. ● Prior bypass surgery with native 3-vessel disease and failure of multiple bypass grafts
● LIMA was used as a graft but is no longer functional
● Depressed LVEF
U (6) A (8)
New and updated indications are shaded blue. *The 2009 appropriate use criteria (1) separated out diabetes and normal or depressed LVEF for the indications in this table, but they were combined
for the focused update because these clinical variables did not affect the ratings.
A  appropriate; CABG  coronary artery bypass graft; CAD  coronary artery disease; CCS  Canadian Cardiovascular Society; CTO  chronic total occlusion; I  inappropriate; LAD  left anterior
descending coronary artery; LIMA  left internal mammary artery; LVEF  left ventricular ejection fraction; PCI  percutaneous coronary intervention; SYNTAX  Synergy Between PCI With TAXUS and
Cardiac Surgery; U  uncertain.
